These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 38752280)

  • 1. BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; AlAseeri AA; Alruwaili M; Saad HM; Batiha GE
    J Cell Mol Med; 2024 May; 28(10):e18368. PubMed ID: 38752280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.
    Kang SS; Zhang Z; Liu X; Manfredsson FP; Benskey MJ; Cao X; Xu J; Sun YE; Ye K
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10773-10778. PubMed ID: 28923922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
    Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
    Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.
    Ding YX; Xia Y; Jiao XY; Duan L; Yu J; Wang X; Chen LW
    Neurochem Res; 2011 Oct; 36(10):1759-66. PubMed ID: 21562748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson's disease.
    Fenner ME; Achim CL; Fenner BM
    J Mol Histol; 2014 Jun; 45(3):349-61. PubMed ID: 24374887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase.
    Kang SS; Wu Z; Liu X; Edgington-Mitchell L; Ye K
    Neurotherapeutics; 2022 Jul; 19(4):1283-1297. PubMed ID: 35595958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
    Jiang Z; Wang J; Sun G; Feng M
    Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.
    Jin W
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31963575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis.
    Ishii T; Warabi E; Mann GE
    Free Radic Biol Med; 2019 Mar; 133():169-178. PubMed ID: 30189266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Głowacka U; Kuter K; Ossowska K
    PLoS One; 2015; 10(3):e0117698. PubMed ID: 25739024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells.
    Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ
    J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration.
    Baydyuk M; Nguyen MT; Xu B
    Exp Neurol; 2011 Mar; 228(1):118-25. PubMed ID: 21192928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson's disease model.
    Farrand AQ; Helke KL; Aponte-Cofresí L; Gooz MB; Gregory RA; Hinson VK; Boger HA
    Behav Brain Res; 2019 Nov; 373():112080. PubMed ID: 31301412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.
    Fontanesi C; Kvint S; Frazzitta G; Bera R; Ferrazzoli D; Di Rocco A; Rebholz H; Friedman E; Pezzoli G; Quartarone A; Wang HY; Ghilardi MF
    Neurorehabil Neural Repair; 2016 Jun; 30(5):411-8. PubMed ID: 26253177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson's disease model.
    Salari Z; Ashabi G; Fartoosi A; Fartoosi A; Shariatpanahi M; Aghsami M; Montazeri H; Kheradmand A
    BMC Pharmacol Toxicol; 2023 Nov; 24(1):60. PubMed ID: 37936189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease.
    Ding Y; Botchway BOA; Zhang Y; Liu X
    Food Funct; 2023 Jun; 14(12):5537-5550. PubMed ID: 37279045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
    von Bohlen und Halbach O; Minichiello L; Unsicker K
    FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype.
    Kim HI; Lee S; Lim J; Chung S; Koo TS; Ji YG; Suh YG; Son WS; Kim SH; Choi HJ
    Pharmacol Res; 2021 Mar; 165():105423. PubMed ID: 33434621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.